Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00782145 · ClinicalTrials.gov registry record · Phase 3
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families
A Phase 3 study of Ovarian Cancer and Lymphoma, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 198
- Enrollment target
- 6
- Study locations
NCT00782145: Completed Phase 3 study of Ovarian Cancer and Lymphoma, sponsored by Tufts Medical Center.
NCT00782145 is a Phase 3 study of Ovarian Cancer and Lymphoma that has completed, run by Tufts Medical Center. The registered enrollment target is 198 participants, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (73% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00782145, a Phase 3 study of Ovarian Cancer and Lymphoma, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 198 participants
- Enrollment target
- 6
- Study locations
Study Summary
RATIONALE: A Web site for stem cell transplant health information and support may be effective in helping parents improve their health-related knowledge, skills, and quality of life, which may also improve their children's quality of life. PURPOSE: This randomized phase III trial is studying a Web-based stem cell transplant support system to see how well it works compared with standard care in families of young patients undergoing a stem cell transplant.
Conditions Studied
Interventions
- OTHER questionnaire administration
- OTHER educational intervention
- OTHER study of socioeconomic and demographic variables
- OTHER informational intervention
- OTHER internet-based intervention
Study Locations (6)
California
- City of Hope Comprehensive Cancer Center - Duarte
Massachusetts
- Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute - Boston
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Wisconsin
- Medical College of Wisconsin Cancer Center - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-06 |
| Phase | Phase 3 |
What the finished NCT00782145 record still lists
NCT00782145 is an interventional study that assigns participants to a tested intervention. The registered 198 participants enrollment target is mid-sized for trials with a published cap, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (73% lower).
The record links to 9 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00782145 lists 6 locations in 6 states (California, Massachusetts, Ohio).
Frequently Asked Questions
What is clinical trial NCT00782145 about?
NCT00782145 is a clinical study titled "A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families". RATIONALE: A Web site for stem cell transplant health information and support may be effective in helping parents improve their health-related knowledge, skills, and quality of life, which may also improve their children's quality of life. PURPOSE: This randomized phase III trial is studying a Web-...
What is the current status of trial NCT00782145?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 198 participants. The study started on 2008-06. Estimated completion is 2011-06.
What conditions does trial NCT00782145 study?
This clinical trial studies the following conditions: Ovarian Cancer, Lymphoma, Leukemia, Myelodysplastic Syndromes, Sarcoma.
What interventions are being tested in trial NCT00782145?
The interventions under investigation include: questionnaire administration (OTHER), educational intervention (OTHER), study of socioeconomic and demographic variables (OTHER), informational intervention (OTHER), internet-based intervention (OTHER).
Who is sponsoring clinical trial NCT00782145?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00782145 being conducted?
This trial has 6 study locations across California, Massachusetts, Ohio, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00782145's enrollment target sits among peer trials
198 101st of 322 higher than 222 of 322 other Ovarian Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ovarian Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
RECRUITING · Phase 3
-
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RECRUITING · Phase 3
-
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
RECRUITING · Phase 3
-
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
RECRUITING · Phase 3
-
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RECRUITING · Phase 3
-
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
- NCT05561114 · 198 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
- NCT05585190 · 198 participants · NA
Stand Up for Your Health with a Sit-stand Desk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia